Stephen Ethier to Breast Neoplasms
This is a "connection" page, showing publications Stephen Ethier has written about Breast Neoplasms.
Connection Strength
6.251
-
Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer. BMC Cancer. 2019 May 23; 19(1):491.
Score: 0.335
-
Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERa in SUM-44 breast cancer cells and is associated with ERa over-expression in breast cancer. Mol Oncol. 2016 06; 10(6):850-65.
Score: 0.268
-
Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes. Exp Cell Res. 2015 Mar 15; 332(2):223-35.
Score: 0.250
-
Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer. Mol Oncol. 2015 Feb; 9(2):527-43.
Score: 0.244
-
KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia. 2014 Aug; 16(8):644-55.
Score: 0.240
-
Oncogene activation induces metabolic transformation resulting in insulin-independence in human breast cancer cells. PLoS One. 2011 Mar 17; 6(3):e17959.
Score: 0.190
-
Transforming properties of 8p11-12 amplified genes in human breast cancer. Cancer Res. 2010 Nov 01; 70(21):8487-97.
Score: 0.185
-
Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers. Int J Cancer. 2009 Oct 01; 125(7):1613-21.
Score: 0.172
-
Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop. Cell Signal. 2009 Feb; 21(2):212-9.
Score: 0.161
-
Amphiregulin as a novel target for breast cancer therapy. J Mammary Gland Biol Neoplasia. 2008 Jun; 13(2):171-9.
Score: 0.156
-
Transforming properties of TC-1 in human breast cancer: interaction with FGFR2 and beta-catenin signaling pathways. Int J Cancer. 2007 Sep 15; 121(6):1265-73.
Score: 0.149
-
Activation of a nuclear factor kappaB/interleukin-1 positive feedback loop by amphiregulin in human breast cancer cells. Mol Cancer Res. 2007 Aug; 5(8):847-61.
Score: 0.148
-
Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res. 2006 Dec 15; 66(24):11632-43.
Score: 0.142
-
Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells. J Biol Chem. 2006 Dec 08; 281(49):37728-37.
Score: 0.140
-
Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon. Oncogene. 2007 Mar 29; 26(14):2104-14.
Score: 0.139
-
Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells. Oncogene. 2005 Apr 28; 24(19):3177-86.
Score: 0.126
-
Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines. Cancer Genet Cytogenet. 2004 Nov; 155(1):57-62.
Score: 0.122
-
Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells. Mol Cancer Res. 2004 Nov; 2(11):643-52.
Score: 0.122
-
Chromosomal instability and lack of cyclin E regulation in hCdc4 mutant human breast cancer cells. Breast Cancer Res. 2004; 6(5):R531-9.
Score: 0.120
-
Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Res. 2004 Jan 01; 64(1):40-7.
Score: 0.115
-
Identifying and validating causal genetic alterations in human breast cancer. Breast Cancer Res Treat. 2003 Apr; 78(3):285-7.
Score: 0.109
-
Epidermal growth factor receptor signaling and response of cancer cells to ionizing radiation. J Natl Cancer Inst. 2001 Jun 20; 93(12):890-1.
Score: 0.097
-
Radiosensitization of human breast cancer cells by a novel ErbB family receptor tyrosine kinase inhibitor. Int J Radiat Oncol Biol Phys. 2000 Dec 01; 48(5):1519-28.
Score: 0.093
-
Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE. Breast Cancer Res. 2000; 2(4):311-20.
Score: 0.090
-
ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells. Br J Cancer. 2000 Feb; 82(3):666-74.
Score: 0.088
-
Molecular cytogenetic analysis of 11 new breast cancer cell lines. Br J Cancer. 1999 Dec; 81(8):1328-34.
Score: 0.087
-
Constitutive activation of pp125fak in newly isolated human breast cancer cell lines. Breast Cancer Res Treat. 1999 Mar; 54(2):173-82.
Score: 0.082
-
Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res. 1997 Mar 01; 57(5):978-87.
Score: 0.072
-
Functional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death. Oncotarget. 2016 Jun 14; 7(24):36138-36153.
Score: 0.068
-
MYC Is a Crucial Mediator of TGF?-Induced Invasion in Basal Breast Cancer. Cancer Res. 2016 06 15; 76(12):3520-30.
Score: 0.068
-
Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2. Mol Carcinog. 1996 Mar; 15(3):227-38.
Score: 0.067
-
erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. Cancer Res. 1996 Feb 15; 56(4):899-907.
Score: 0.067
-
Human breast cancer cell lines as models of growth regulation and disease progression. J Mammary Gland Biol Neoplasia. 1996 Jan; 1(1):111-21.
Score: 0.066
-
Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer. Breast Cancer Res. 2015 Sep 22; 17:130.
Score: 0.065
-
Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst. 1995 Jul 05; 87(13):964-73.
Score: 0.064
-
Finite proliferative lifespan in vitro of a human breast cancer cell strain isolated from a metastatic lymph node. Breast Cancer Res Treat. 1993 Dec; 28(3):267-76.
Score: 0.057
-
Insulin like growth factor-I independence in rat mammary carcinoma cells: a dominant phenotype in somatic cell hybrid experiments. Cancer Lett. 1993 Nov 01; 74(3):189-95.
Score: 0.057
-
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes. Mol Oncol. 2012 Oct; 6(5):494-506.
Score: 0.052
-
ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways. BMC Cancer. 2012 Jun 08; 12:225.
Score: 0.052
-
Induction of proapoptotic antibodies to triple-negative breast cancer by vaccination with TRAIL death receptor DR5 DNA. Int J Cancer. 2012 Dec 01; 131(11):2562-72.
Score: 0.051
-
Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res. 2011 Oct 01; 71(19):6195-207.
Score: 0.049
-
Identification and functional analysis of 9p24 amplified genes in human breast cancer. Oncogene. 2012 Jan 19; 31(3):333-41.
Score: 0.048
-
Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res. 2011 Feb 15; 71(4):1292-301.
Score: 0.047
-
HER-2 signaling, acquisition of growth factor independence, and regulation of biological networks associated with cell transformation. Cancer Res. 2010 Oct 15; 70(20):7862-73.
Score: 0.046
-
Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo. Cancer Res. 2010 May 15; 70(10):3996-4004.
Score: 0.045
-
Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene. 2009 Dec 17; 28(50):4491-500.
Score: 0.043
-
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res Treat. 2010 May; 121(1):53-64.
Score: 0.042
-
Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study. Cancer Res. 2008 Dec 15; 68(24):10045-50.
Score: 0.041
-
ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer. Cancer Res. 2008 Nov 01; 68(21):8908-17.
Score: 0.040
-
Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells. Cancer Res. 2008 May 01; 68(9):3314-22.
Score: 0.039
-
Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines. Breast Cancer Res Treat. 2009 Jan; 113(2):285-91.
Score: 0.038
-
Comprehensive analysis of oncogenic effects of PIK3CA mutations in human mammary epithelial cells. Breast Cancer Res Treat. 2008 Nov; 112(2):217-27.
Score: 0.038
-
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet. 2008 Jan; 40(1):102-7.
Score: 0.038
-
p38MAPK-activated AKT in HER-2 overexpressing human breast cancer cells acts as an EGF-independent survival signal. J Surg Res. 2007 Sep; 142(1):162-9.
Score: 0.037
-
Differential signal transduction of alternatively spliced FGFR2 variants expressed in human mammary epithelial cells. J Cell Physiol. 2007 Mar; 210(3):720-31.
Score: 0.036
-
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006 Dec; 10(6):515-27.
Score: 0.035
-
New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK. Breast Cancer Res Treat. 2006 Nov; 100(2):237-8.
Score: 0.034
-
Differential phosphoprotein mapping in cancer cells using protein microarrays produced from 2-D liquid fractionation. Anal Chem. 2006 Feb 01; 78(3):702-10.
Score: 0.033
-
BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res. 2006 Jan 01; 66(1):41-5.
Score: 0.033
-
Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol Cancer Res. 2005 Dec; 3(12):655-67.
Score: 0.033
-
Cooperative interactions of HER-2 and HPV-16 oncoproteins in the malignant transformation of human mammary epithelial cells. Neoplasia. 2005 Aug; 7(8):788-98.
Score: 0.032
-
Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells. Cancer Res. 2004 Dec 01; 64(23):8674-81.
Score: 0.031
-
Cleavage of beta-catenin by calpain in prostate and mammary tumor cells. Cancer Res. 2004 Oct 15; 64(20):7237-40.
Score: 0.030
-
Stat3 modulates heat shock 27kDa protein expression in breast epithelial cells. Biochem Biophys Res Commun. 2004 Jan 30; 314(1):143-50.
Score: 0.029
-
Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res. 2003 Jan 01; 63(1):132-9.
Score: 0.027
-
Lack of functional pRb results in attenuated recovery of mRNA synthesis and increased apoptosis following UV radiation in human breast cancer cells. Oncogene. 2002 Jul 04; 21(29):4481-9.
Score: 0.026
-
Detection of ductal dysplasia in mammary outgrowths derived from carcinogen-treated virgin female BALB/c mice. Cancer Res. 1982 May; 42(5):1753-60.
Score: 0.026
-
Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res. 2001 Jul 01; 61(13):5168-78.
Score: 0.024
-
Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes Chromosomes Cancer. 2000 Dec; 29(4):356-62.
Score: 0.023
-
Lack of RB protein correlates with increased sensitivity to UV-radiation-induced apoptosis in human breast cancer cells. Radiat Res. 2000 Nov; 154(5):590-9.
Score: 0.023
-
Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res. 2000 Aug 15; 60(16):4519-25.
Score: 0.023
-
Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells. J Cell Physiol. 2000 Jun; 183(3):301-13.
Score: 0.022
-
SUM-159PT cells: a novel estrogen independent human breast cancer model system. Breast Cancer Res Treat. 1999 Dec; 58(3):193-204.
Score: 0.022
-
A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res. 1999 Sep; 5(9):2511-9.
Score: 0.021
-
erbB-2 overexpression in human mammary epithelial cells confers growth factor independence. Endocrinology. 1999 Aug; 140(8):3615-22.
Score: 0.021
-
BRCA1 protein level is not affected by peptide growth factors in MCF10A cell line. Oncogene. 1996 Dec 05; 13(11):2487-91.
Score: 0.018
-
Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification. Cell Growth Differ. 1996 May; 7(5):551-61.
Score: 0.017
-
Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol. 1994 Mar; 12(3):475-82.
Score: 0.015
-
Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res. 1993 Feb 01; 53(3):627-35.
Score: 0.014
-
The influence of growth factors on the proliferative potential of normal and primary breast cancer-derived human breast epithelial cells. Breast Cancer Res Treat. 1991 Jan-Feb; 17(3):221-30.
Score: 0.012
-
Editorial: Cost-effective analyses in Breast Cancer Research and Treatment [corrected]. Breast Cancer Res Treat. 2009 May; 115(2):221-2.
Score: 0.010
-
Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ. 1997 Dec; 8(12):1267-76.
Score: 0.005
-
Carcinogenic polycyclic aromatic hydrocarbons increase intracellular Ca2+ and cell proliferation in primary human mammary epithelial cells. Carcinogenesis. 1997 Jun; 18(6):1177-82.
Score: 0.005
-
Fluorine-18-fluorodeoxyglucose-guided breast cancer surgery with a positron-sensitive probe: validation in preclinical studies. J Nucl Med. 1995 Oct; 36(10):1869-74.
Score: 0.004